Morphic Therapeutic to Present at the 40th Annual Cowen Health Care Conference
February 28, 2020 08:00 ET
|
Morphic Therapeutic
WALTHAM, Mass., Feb. 28, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral therapies targeting integrins for the treatment...